GALECTIN THERAPEUTICS INC Uncategorized Contracts & Agreements
40 Contracts & Agreements
- Supplemental Line of Credit Agreement, dated as of March 29, 2024, by and between Richard E. Uihlein and the Company (Filed With SEC on March 29, 2024)
- Form of Convertible Promissory Note issued to Richard E. Uihlein (Filed With SEC on March 29, 2024)
- Form of Restricted Stock Unit Award Agreement under Galectin Therapeutics 2019 Omnibus Equity Incentive Plan (Filed With SEC on March 29, 2024)
- Form of Stock Option Award Agreement under Galectin Therapeutics 2019 Omnibus Equity Incentive Plan (Filed With SEC on March 29, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on March 29, 2024)
- Warrant Extension Agreement between the Company and 10X Fund L.P (Filed With SEC on March 29, 2024)
- Description of Registrants securities (Filed With SEC on March 31, 2021)
- Work Order, dated as of June 22, 2020, by and between Galectin Therapeutics Inc. and Covance Inc (Filed With SEC on June 26, 2020)
- Work Order, dated as of March 12, 2020, by and between Galectin Therapeutics, Inc. and Covance Clinical Research Unit Inc (Filed With SEC on March 17, 2020)
- LOCK-UP LETTER AGREEMENT September 22, 2016 (Filed With SEC on September 27, 2016)
- EXHIBIT A (Filed With SEC on June 20, 2016)
- EXHIBIT A (Filed With SEC on June 20, 2016)
- PROJECT ADDENDUM (Filed With SEC on March 12, 2015)
- GALECTIN THERAPEUTICS INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA (Filed With SEC on March 30, 2012)
- AGREEMENT (Filed With SEC on January 27, 2011)
- 10X FUND, L.P. 1099 Forest Lake Terrace Niceville, Florida 32578 February 11, 2010 (Filed With SEC on February 17, 2010)
- 10X FUND, L.P. 1099 Forest Lake Terrace (Filed With SEC on August 14, 2009)
- TECHNOLOGY TRANSFER AND SHARING AGREEMENT (Filed With SEC on February 18, 2009)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 18, 2009)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 18, 2009)
- FORM OF BENEFICIAL OWNER ELECTION (Filed With SEC on February 2, 2009)
- [FORM OF NOTICE TO STOCKHOLDERS ACTING AS NOMINEES] PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 2, 2009)
- [FORM OF NOTICE TO STOCKHOLDERS] PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 2, 2009)
- FORM OF PRO-PHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENT ___________, 2009 (Filed With SEC on February 2, 2009)
- FORM OF BENEFICIAL OWNER ELECTION (Filed With SEC on November 19, 2008)
- [FORM OF NOTICE TO STOCKHOLDERS ACTING AS NOMINEES] PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2008)
- [FORM OF NOTICE TO STOCKHOLDERS] PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2008)
- Pro-Pharmaceuticals, Inc. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA (Filed With SEC on November 19, 2008)
- SUBJECT TO LEGAL REVIEW AND COMMITMENT COMMITTEE APPROVAL (Filed With SEC on February 15, 2008)
- Members NASD & SIPC 405 Lexington Ave. * New York, NY 10174 * Tel ###-###-#### * (800) 724-0761 * fax ###-###-#### * www.maximgrp.com New York, NY * Long Island, NY * Chicago, IL... (Filed With SEC on February 15, 2008)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on December 21, 2007)
- Name: (Filed With SEC on October 9, 2007)
- DUEFEBRUARY , 2008 (Filed With SEC on February 15, 2006)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 11, 2005)
- OPTION AGREEMENT (Filed With SEC on November 19, 2004)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2004)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2004)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2004)
- PRO-PHARMACEUTICALS, INC. (Filed With SEC on March 30, 2004)
- Pro-Pharmaceuticals, Inc. (Filed With SEC on March 30, 2004)
